المؤلفون: Raharja, Antony, Arkir, Zehra, Rinaldi, Giulia, Tsakok, Teresa, Dasandi, Tejus, Guard, Sarah, McGuire, Arlene, Pink, Andrew E., Woolf, Richard, Barker, Jonathan N., Smith, Catherine H., Mahil, Satveer K.

المساهمون: Psoriasis Association, NIHR BRC, National Institute for Health and Care Research

المصدر: Journal of Investigative Dermatology ; volume 143, issue 9, page 1708-1716.e4 ; ISSN 0022-202X

مصطلحات موضوعية: Cell Biology, Dermatology, Molecular Biology, Biochemistry

الإتاحة: https://doi.org/10.1016/j.jid.2023.01.033Test
https://api.elsevier.com/content/article/PII:S0022202X23001604?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0022202X23001604?httpAccept=text/plainTest

المؤلفون: Chanchlani, Neil, Lin, Simeng, Chee, Desmond, Hamilton, Benjamin, Nice, Rachel, Arkir, Zehra, Bewshea, Claire, Cipriano, Bessie, Derikx, Lauranne A. A. P., Dunlop, Allan, Greathead, Louise, Griffiths, Rachel L., Ibraheim, Hajir, Kelleher, Peter, Kok, Klaartje B., Lees, Charlie W., MacDonald, Jonathan, Sebastian, Shaji, Smith, Philip J., McDonald, Timothy J., Irving, Peter M., Powell, Nick, Kennedy, Nicholas A., Goodhand, James R., Ahmad, Tariq

المصدر: Chanchlani , N , Lin , S , Chee , D , Hamilton , B , Nice , R , Arkir , Z , Bewshea , C , Cipriano , B , Derikx , L A A P , Dunlop , A , Greathead , L , Griffiths , R L , Ibraheim , H , Kelleher , P , Kok , K B , Lees , C W , MacDonald , J , Sebastian , S , Smith , P J , McDonald , T J , Irving , P M , Powell , N , Kennedy , ....

مصطلحات موضوعية: adalimumab, biologic, CLARITY, COVID-19, immunosuppression, inflammatory bowel disease, infliximab, vaccination, vedolizumab

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1093/ecco-jcc/jjab153Test
https://kclpure.kcl.ac.uk/portal/en/publications/1fd256f3-70ad-4c8d-b7f5-eed520031c42Test
https://kclpure.kcl.ac.uk/ws/files/170412073/Adalimumab_and_Infliximab_Impair_CHANCHLANI_Published_online_2_Sept_21_GOLD_VoR_CC_BY_NC_.pdfTest
http://www.scopus.com/inward/record.url?scp=85126490511&partnerID=8YFLogxKTest

المؤلفون: Luber, Raphael P., O'Neill, Rhona, Singh, Sukhpreet, Sharma, Esha, Cunningham, Georgina, Honap, Sailish, Meade, Susanna, Ray, Shuvra, Anderson, Simon H., Mawdsley, Joel, Sanderson, Jeremy D., Samaan, Mark A., Arkir, Zehra, Irving, Peter M.

المصدر: Luber , R P , O'Neill , R , Singh , S , Sharma , E , Cunningham , G , Honap , S , Meade , S , Ray , S , Anderson , S H , Mawdsley , J , Sanderson , J D , Samaan , M A , Arkir , Z & Irving , P M 2021 , ' An observational study of switching infliximab biosimilar : no adverse impact on inflammatory bowel disease control or drug levels with first or second switch ' , Alimentary Pharmacology and Therapeutics , vol. 54 , no. 5 ....

الإتاحة: https://doi.org/10.1111/apt.16497Test
https://kclpure.kcl.ac.uk/portal/en/publications/194c2446-89aa-40af-a1fe-9bba16e01d6eTest
http://www.scopus.com/inward/record.url?scp=85109103844&partnerID=8YFLogxKTest

المؤلفون: Chanchlani, Neil, Lin, Simeng, Chee, Desmond, Hamilton, Benjamin, Nice, Rachel, Arkir, Zehra, Bewshea, Claire, Cipriano, Bessie, Derikx, Lauranne A A P, Dunlop, Allan, Greathead, Louise, Griffiths, Rachel L, Ibraheim, Hajir, Kelleher, Peter, Kok, Klaartje B, Lees, Charlie W, MacDonald, Jonathan, Sebastian, Shaji, Smith, Philip J, McDonald, Timothy J, Irving, Peter M, Powell, Nick, Kennedy, Nicholas A, Goodhand, James R, Ahmad, Tariq

المصدر: Journal of Crohn's and Colitis ; volume 16, issue 3, page 389-397 ; ISSN 1873-9946 1876-4479

الإتاحة: https://doi.org/10.1093/ecco-jcc/jjab153Test
https://academic.oup.com/ecco-jcc/article-pdf/16/3/389/42893787/jjab153.pdfTest

المؤلفون: Samaan, Mark A, Cunningham, Georgina, Tamilarasan, Aravind Gokul, Rawstron, Krystal, Hawash, Karim, Beltran, Luisa, Koumoutsos, Ioannis, Ray, Shuvra, Mawdsley, Joel, Anderson, Simon H, Sanderson, Jeremy D, Arkir, Zehra, Irving, Peter M

المصدر: Inflammatory Bowel Disease

الإتاحة: https://doi.org/10.1136/gutjnl-2019-bsgabstracts.124Test

المؤلفون: Tamilarasan, Aravind Gokul, Guerrero, Antonio, Arias, Laura, Burns, Megan, Arkir, Zehra, Irving, Peter

المصدر: Posters

الإتاحة: https://doi.org/10.1136/gutjnl-2019-bsgabstracts.187Test

المؤلفون: Samaan, Mark, Arkir, Zehra, Irving, Peter, Chuter, Charlotte

المصدر: IBD

الإتاحة: https://doi.org/10.1136/gutjnl-2018-bsgabstracts.179Test

المؤلفون: Langford, Thomas, Arkir, Zehra, Chalkidou, Anastasia, Goddard, Kate, Kaftantzi, Lamprini, Samaan, Mark, Irving, Peter

المصدر: Langford , T , Arkir , Z , Chalkidou , A , Goddard , K , Kaftantzi , L , Samaan , M & Irving , P 2018 , ' The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients : Protocol for a Validation Study ' , JMIR research protocols , vol. 7 , no. 10 , e11218 . https://doi.org/10.2196/11218Test

مصطلحات موضوعية: Anti-TNF, Antidrug antibodies, Crohn’s disease, ELISA, Inflammatory bowel disease, Infliximab, Therapeutic drug monitoring

الإتاحة: https://doi.org/10.2196/11218Test
https://kclpure.kcl.ac.uk/portal/en/publications/da913e35-9410-407e-8b94-10d74230cbffTest
http://www.scopus.com/inward/record.url?scp=85102368064&partnerID=8YFLogxKTest

المؤلفون: Claire Bewshea, James R Goodhand, Peter Kelleher, Nick Powell, Rachel L Griffiths, Nicholas A. Kennedy, Philip J Smith, Shaji Sebastian, Arkir Zehra, Bessie Cipriano, Desmond Chee, Louise Greathead, Benjamin Hamilton, Simeng Lin, Rachel Nice, Lauranne A A P Derikx, Neil Chanchlani, Hajir Ibraheim, Peter M. Irving, Klaartje Kok, Charlie W. Lees, Jonathan Macdonald, Timothy J. McDonald, Allan Dunlop, Tariq Ahmad

المصدر: Journal of Crohn's and Colitis, 16, 3, pp. 389-397
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 16, 389-397
Chanchlani, N, Lin, S, Chee, D, Hamilton, B, Nice, R, Arkir, Z, Bewshea, C, Cipriano, B, Derikx, L A A P, Dunlop, A, Greathead, L, Griffiths, R L, Ibraheim, H, Kelleher, P, Kok, K B, Lees, C W, MacDonald, J, Sebastian, S, Smith, P J, McDonald, T J, Irving, P M, Powell, N, Kennedy, N A, Goodhand, J R & Ahmad, T 2022, ' Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses : Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 389-397 . https://doi.org/10.1093/ecco-jcc/jjab153Test

مصطلحات موضوعية: Male, TNF, Gastroenterology, Serology, Seroepidemiologic Studies, adalimumab, skin and connective tissue diseases, immunosuppression, biology, medicine.diagnostic_test, General Medicine, Eccojc/1020, Original Article, Drug Monitoring, Antibody, Life Sciences & Biomedicine, biologic, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], medicine.drug, vedolizumab, Adult, medicine.medical_specialty, Combination therapy, MATURATION, Vedolizumab, DEFICIENT, inflammatory bowel disease, Internal medicine, Adalimumab, medicine, Humans, Seroprevalence, AcademicSubjects/MED00260, Biological Products, Science & Technology, Gastroenterology & Hepatology, SARS-CoV-2, business.industry, COVID-19, 1103 Clinical Sciences, vaccination, Inflammatory Bowel Diseases, Infliximab, ALPHA, Therapeutic drug monitoring, CLARITY, Antibody Formation, biology.protein, Tumor Necrosis Factor Inhibitors, infliximab, business, INFLAMMATORY-BOWEL-DISEASE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c08447d7329ab51228946a10f8ee899Test

المؤلفون: Samaan, Mark, Cunningham, Georgina, Tamilarasan, Gokul, Rawstron, Krystal, Hawash, Karim, Beltran, Luisa, Ray, Shuvra, Mawdsley, Joel, Anderson, Simon, Sanderson, Jeremy, Arkir, Zehra, Irving, Peter

المصدر: Posters

الإتاحة: https://doi.org/10.1136/gutjnl-2020-bsgcampus.219Test